Cannabidiol as an Adjunctive Treatment for Bipolar Depression

NCT03310593 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

36

Enrollment

OTHER

Sponsor class

Stopped It was interrupted due to the coronavirus pandemic outbreak.

Conditions

Bipolar Disorder
Bipolar Depression
Bipolar Affective Disorder

Interventions

DRUG: Cannabidiol
DRUG: Placebo

Sponsor

Hospital de Clinicas de Porto Alegre

Collaborators

[object Object]
[object Object]